NCT01123408View on ClinicalTrials.gov

Clozapine and Olanzapine Treatment of Aggression

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Schizophrenia
Interventions
DRUG

Clozapine

500 mg/day

DRUG

Olanzapine

20 mg/day

DRUG

Haloperidol

20 mg/day

Trial Locations (1)

10962

Nathan Kline Institute, Orangeburg

All Listed Sponsors
lead

Nathan Kline Institute for Psychiatric Research

OTHER

NCT01123408 - Clozapine and Olanzapine Treatment of Aggression | Biotech Hunter | Biotech Hunter